Phase 2 Safety Data For Anti-RSV Antibody And National RSV Surveillance Results Announced By Medimmune
Oct 5th 2007Drug InformationInfectious Diseases / Bacteria / Viruses
MedImmune, Inc. has announced results from two important studies presented at the 2007 Infectious Diseases Society of America (IDSA) 45th Annual Meeting adding to the body of knowledge about respiratory syncytial virus (RSV). RSV is a viral pathogen that produces annual outbreaks usually between fall and spring. [click link for full article]
More: continued here
No Comments »
Leave a Reply
You must be logged in to post a comment.
